Lecture slides week 1 Flashcards

1
Q

What is rational prescribing?

A

Prescribing decisions that are
-evidence based
-interpreted in the context of factors not accounted for in any clinical trial (system, patient, drug, prescriber)
-maximize effectiveness
-minimize harms
-avoid waste of resources
-respect patient choice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe patient factors that affect prescribing

A

Diagnosis, medical history (allergies, genetics, risk factors, comorbidities), drug history (i.e., history of adverse effects), exam findings, investigations (labs, XR, urine, etc.), ability to obtain/ pay for Rx, ability to follow instructions, prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe drug factors influencing prescribing

A

Side effects, interactions with patient (their comorbidities, other drugs they are on), kinetics and dynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe prescriber factors influencing prescribing

A

Provider familiarity/ comfort, ability to make referrals/ follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe system factors influencing prescribing

A

Drug availability, insurance coverage, restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the rational prescribing process

A

Diagnosis
Prognosis
Goals of therapy
Treatment selection
Monitoring and follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the most important component of making the diagnosis?

A

History per Susan (helps form ddx, obtain allergies/ hx )
If you don’t have time to do a hx/ physical/ ddx, you probably aren’t prescribing rationally!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What components are important in making a diagnosis?

A

History, physical, differentials, diagnostics (if necessary), working diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does prognosis affect prescribing decisions?

A

Prognosis helps shape goals of care
I.e., QOL goals vs. curative intent
What is the patient willing to do? Will they be able to use the therapy? Do comorbidities (i.e., liver, kidney) affect the drug choice? (i.e., patient with declining liver fcn).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name a few different goals of therapy

A

Cure, relief of symptoms, long term prevention of negative effects of disease, replacing deficiencies, therapeutic trials to aid in diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When there is more than one treatment option available, how do you decide which one to pick?

A

-Maximize benefit harm balance, consider patient factors, drug factors, prescriber factors
i.e., drug availability, cost, community support, side effect profile, dosing profile, your competence/ experience with a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F Drugs in the same class may have different bioavailability, dose concentration curves, and half lives that will determine their dosing schedule

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some pharmacokinetic factors to consider when prescribing?

A

Absorption- what route is feasible/ will the patient tolerate?
Distribution- i.e., giving an anemic person a highly protein bound drug won’t work
Metabolism: any drug interactions to be aware of? How is their liver function?
Excretion: Kidney function/ adjusting for renal dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some pharmacodynamic factors to consider when prescribing?

A

Therapeutic index
Dose response curve
Need for monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T/F when choosing between drug A and B, you want to pick the drug with a more narrow therapeutic index in order to have precise effects

A

False- want wider for less chance of side effect or toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F Rational prescribing means making prescribing decisions based on the specific disease process

A

False- make decisions based on the patient, not the diseasee

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some consequences of irrational prescribing?

A

Low benefit, increased risk of harm, reduced adherence, unnecessary cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is multimorbidity?

A

Multiple (2+) long term conditions (can be physical/ mental, learning disabilities, sensory or spectrum disorder, alcohol and substance misuse)

19
Q

What is deprescribing?

A

Planned and supervised process of dose reduction or stopping medication that might be causing harm, is is no longer of benefit.
Part of good prescribing.

20
Q

How might one incorporate principles of deprescribing into practice/

A

-review prescribed, OTC, supplemental therapies at every encounter
-reduce or discontinue preventive medications when benefit is no longer a consideration (i.e., when 2-10 year outcomes will not be achieved)
-reduce or discontinue medications that are not needed or could be replaced by something less harmful

21
Q

Define pharmacotherapeutics

A

The study of the therapeutic uses and effects of drug

22
Q

For clinicians to be safe and effective in their approach to therapeutics, they should have a strong understanding of the ______________ and __________________ of drug therapy.

Pick from: safety profile, cost effectiveness, kinetics, dynamics, tailoring, negatives, benefits, harms

A

Kinetics and dynamics. You need to know the kinetics and dynamics to be safe!!!

23
Q

What is pharmacokinetics?

A

Study of absorption, distribution, metabolism, and elimination of drugs
(Body effect on drugs)

24
Q

Why do we care about pharmacokinetics?

A

Determines how rapidly and for how long the drug will appear at the target organ

25
Q

Define absorption:

A

The method in which a drug is introduced to the body

26
Q

What is the general relationship between route of absorption and onset of pharmacologic effect?

A

In general, the pharmacological effect that is desired will be delayed the further it is away from the systemic circulation

27
Q

Describe some drug factors influencing absorption

A

Route of administration, dosage form, molecular weight, lipid solubility, degree of ionization, drug solubility, chemical stability in gastric pH

28
Q

What patient factors influence absorption?

A

Body size, maturation of organ function, pathologic processes

29
Q

What is bioavailability?

A

In a typical use of the drug, how much is available AT THE SITE OF ACTION unchanged

30
Q

Do I need to calculate bioavailability for every patient?

A

No, drugs come with bioavailability information. It is the “best case scenario” how much drug will be at the side of action unchanged. The drug is designed this way.

31
Q

How does oral vs. IV administration of a drug influence its effect?

A

Oral- GI system > liver > circulation (takes more time, subject to first pass metabolism by liver)
IV > enters directly into circulation, bypassing the GI system and liver

32
Q

Which route has the most immediate peak concentration in the blood? Inhalation, oral, or intravenous

A

Inhalation > intravenous > oral
Inhaled drugs reach arterial circulation faster than drugs injected into the vein

33
Q

Define bioavailability

A

Concentration of drug available at site of action unchanged.

Here is another definition from the slide set:
The fraction of drug that is available unchanged that is absorbed into the systemic circulation after extravascular administration and passing the biologic barriers is defined as its bioavailability

34
Q

What influences bioavailability?

A

Dose of drug, availability of membrane transported, amount of drug that enters systemic circulation, volume of distribution, how quickly metabolism and excretion take place

35
Q

Why is drug binding significant in kinetics?

A

Drugs may bind to transport proteins in the blood to travel around circulation. However, it is important to note that only unbound drug (1) provides the driving force for distribution of the agent to the body tissues (2) has effects on its intended target

36
Q

T/F Binding (by a tissue or protein) is reversible

A

Usually yes- this allows unbound and bound forms of the drug to find an equilibrium in the body.

37
Q

What may cause a drug to be incompletely absorbed?

A

-Poor absorption in gut
-Too hydrophilic- cant cross lipid cell membrane
-Too lipophilic- cant’ cross the water layer adjacent to the cell

38
Q

How may a drug be transported across the cell membrane?

A

I don’t think we need to know this, but included it anyways.

Paracellular transport (water soluble agents)
Diffusion (lipid soluble agents, i.e., antidepressants, nicotine, alcohol)
Protein transporters (i.e., glcuose, amino acids, cyclosporin, gabapentin)
Receptor mediated transcytosis (i.e., insulin, interleukins)
Absorptive transcytosis (i.e., albumin)
Efflux transportation (i.e., cetirizine)

39
Q

T/ F Rate of absorption is different from extent of absorption

A

True

40
Q

T/ F Rate of absorption is determined by the site of administration and the drug formulation (bioavailability)

A

True

41
Q

Why is understanding the difference in rate of absorption and the degree of bioavailability important?

A

Determines how quickly particular drugs reach target concentrations

42
Q

What is the bioavailability of a drug given IV?

A

100%
(last slide of week 1 lecture 2: Intro to pharmacotherapeutics and pharmacokinetic concepts)

43
Q

What is the bioavailability of a drug given IM or SC?

A

75-100%